Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Biomaterials Research is Scopus-indexed (Q1, CiteScore 13.6), WoS SCIE, DOAJ. It is covered by India's One Nation One Subscription scheme, which pays the article processing charge for authors at eligible institutions. Published by American Association for the Advancement of Science.
Checked against the index lists dated .
ISSN 1226-4601Verify ISSN ↗2055-7124Verify ISSN ↗
Publisher: American Association for the Advancement of Science
Cost to publish: APC covered for authors at ONOS-subscribed Indian institutions
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Medicine (miscellaneous) | 26 / 466 | 94th | Q1 |
| Ceramics and Composites | 13 / 133 | 90th | Q1 |
| Biomedical Engineering | 33 / 342 | 90th | Q1 |
| Biomaterials | 20 / 146 | 86th | Q1 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription)
Yes — actively indexed in Scopus, coverage 2014–present, best quartile Q1, CiteScore 13.6.
Biomaterials Research is Q1 in Medicine (miscellaneous) (rank 26 of 466), Q1 in Ceramics and Composites (rank 13 of 133) and Q1 in Biomedical Engineering (rank 33 of 342), by CiteScore 2025. It is ranked in 4 subject areas in all.
Biomaterials Research is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 13.6, which places it in quartile Q1 at the 94th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.661, quartile Q1, with an H-index of 65.
For authors at Indian institutions covered by One Nation One Subscription (ONOS), the article processing charge is paid by the scheme. The publisher lists an article processing charge of about US$2,700 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Biomaterials Research is published by American Association for the Advancement of Science. Its print ISSN is 1226-4601 and its online ISSN is 2055-7124.
Yes. ONOS also covers its article processing charge for authors at eligible institutions.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Biomaterials Research has an h-index of 80 and a 2-year mean of 6.6 citations per paper (OpenAlex). Its Scopus CiteScore is 13.6, quartile Q1. On 2-year citations it ranks #29 of 451 Scopus journals in Medicine (miscellaneous).
Biomaterials Research published 175 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 98 research articles (2026), authors are most often from China (54.1%), South Korea (26.7%) and United States (7.8%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 2 retracted papers are recorded (2 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.